Accumulating reports subsequently demonstrated that BIS was overexpressed in human cancers of various origins [17, 18], and the degree of BIS expression correlated with the poor prognosis of some cancers, such as pancreatic, thyroid, and glioblastoma [19–21]. Here, BAG3 is linked to cancer.